Inogen, Inc. (INGN)
USD 6.84
(-2.98%)
USD 6.84
(-2.98%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 121.38 Million USD | 12.77% |
| 2022 | 107.63 Million USD | -9.77% |
| 2021 | 119.28 Million USD | 6.29% |
| 2020 | 112.22 Million USD | 9.26% |
| 2019 | 102.71 Million USD | 56.88% |
| 2018 | 65.47 Million USD | 36.32% |
| 2017 | 48.03 Million USD | 50.28% |
| 2016 | 31.96 Million USD | 17.09% |
| 2015 | 27.29 Million USD | 24.44% |
| 2014 | 21.93 Million USD | -15.95% |
| 2013 | 26.09 Million USD | 37.28% |
| 2012 | 19.01 Million USD | 14.7% |
| 2011 | 16.57 Million USD | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q2 | 121.32 Million USD | -1.92% |
| 2024 Q1 | 123.7 Million USD | 1.91% |
| 2023 FY | 121.38 Million USD | 12.77% |
| 2023 Q1 | 104.37 Million USD | -3.03% |
| 2023 Q2 | 99.57 Million USD | -4.6% |
| 2023 Q3 | 113.06 Million USD | 13.55% |
| 2023 Q4 | 121.38 Million USD | 7.35% |
| 2022 Q2 | 113.53 Million USD | -2.41% |
| 2022 Q3 | 118.74 Million USD | 4.59% |
| 2022 Q4 | 107.63 Million USD | -9.35% |
| 2022 FY | 107.63 Million USD | -9.77% |
| 2022 Q1 | 116.33 Million USD | -2.48% |
| 2021 Q1 | 120.19 Million USD | 7.09% |
| 2021 FY | 119.28 Million USD | 6.29% |
| 2021 Q4 | 119.28 Million USD | -2.17% |
| 2021 Q3 | 121.93 Million USD | -4.18% |
| 2021 Q2 | 127.25 Million USD | 5.88% |
| 2020 Q1 | 111.82 Million USD | 8.86% |
| 2020 FY | 112.22 Million USD | 9.26% |
| 2020 Q4 | 112.22 Million USD | 4.08% |
| 2020 Q3 | 107.83 Million USD | 0.77% |
| 2020 Q2 | 107 Million USD | -4.31% |
| 2019 Q1 | 66.3 Million USD | 1.26% |
| 2019 FY | 102.71 Million USD | 56.88% |
| 2019 Q4 | 102.71 Million USD | 1.11% |
| 2019 Q3 | 101.58 Million USD | 45.17% |
| 2019 Q2 | 69.97 Million USD | 5.54% |
| 2018 Q3 | 65.84 Million USD | 0.18% |
| 2018 Q4 | 65.47 Million USD | -0.57% |
| 2018 FY | 65.47 Million USD | 36.32% |
| 2018 Q1 | 53.54 Million USD | 11.48% |
| 2018 Q2 | 65.73 Million USD | 22.76% |
| 2017 Q4 | 48.03 Million USD | -1.08% |
| 2017 Q2 | 43.45 Million USD | 24.67% |
| 2017 Q1 | 34.85 Million USD | 9.05% |
| 2017 Q3 | 48.55 Million USD | 11.74% |
| 2017 FY | 48.03 Million USD | 50.28% |
| 2016 Q2 | 35.28 Million USD | 16.79% |
| 2016 FY | 31.96 Million USD | 17.09% |
| 2016 Q1 | 30.21 Million USD | 10.68% |
| 2016 Q4 | 31.96 Million USD | -17.43% |
| 2016 Q3 | 38.7 Million USD | 9.71% |
| 2015 Q1 | 25.89 Million USD | 18.05% |
| 2015 FY | 27.29 Million USD | 24.44% |
| 2015 Q4 | 27.29 Million USD | -0.92% |
| 2015 Q3 | 27.54 Million USD | -5.92% |
| 2015 Q2 | 29.28 Million USD | 13.08% |
| 2014 Q2 | 34.65 Million USD | 25.54% |
| 2014 Q1 | 27.6 Million USD | 5.76% |
| 2014 FY | 21.93 Million USD | -15.95% |
| 2014 Q4 | 21.93 Million USD | -5.64% |
| 2014 Q3 | 23.24 Million USD | -32.91% |
| 2013 Q2 | 22.79 Million USD | 0.0% |
| 2013 Q3 | 26.66 Million USD | 17.01% |
| 2013 FY | 26.09 Million USD | 37.28% |
| 2013 Q1 | - USD | -100.0% |
| 2013 Q4 | 26.09 Million USD | -2.13% |
| 2012 FY | 19.01 Million USD | 14.7% |
| 2012 Q4 | 19.01 Million USD | 0.0% |
| 2011 FY | 16.57 Million USD | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Accelerate Diagnostics, Inc. | 51.25 Million USD | -136.824% |
| BrainsWay Ltd. | 15.31 Million USD | -692.621% |
| Cerus Corporation | 144.3 Million USD | 15.885% |
| Envoy Medical, Inc. | 9.4 Million USD | -1191.023% |
| electroCore, Inc. | 8.94 Million USD | -1256.982% |
| Helius Medical Technologies, Inc. | 5.34 Million USD | -2172.22% |
| IceCure Medical Ltd | 4.24 Million USD | -2758.065% |
| OrthoPediatrics Corp. | 72.56 Million USD | -67.283% |
| Lucid Diagnostics Inc. | 29.58 Million USD | -310.338% |
| Monogram Orthopaedics, Inc. | 3.18 Million USD | -3714.713% |
| MaxCyte, Inc. | 36.1 Million USD | -236.173% |
| NeuroOne Medical Technologies Corporation | 1.84 Million USD | -6468.61% |
| Nexalin Technology, Inc. | 425.28 Thousand USD | -28441.6% |
| Orthofix Medical Inc. | 326.58 Million USD | 62.833% |
| PAVmed Inc | 57.13 Million USD | -112.44% |
| Rapid Micro Biosystems, Inc. | 25.46 Million USD | -376.7% |
| RxSight, Inc. | 22.18 Million USD | -447.061% |
| Sight Sciences, Inc. | 46.43 Million USD | -161.396% |
| SI-BONE, Inc. | 61.05 Million USD | -98.824% |
| TELA Bio, Inc. | 59.16 Million USD | -105.152% |
| Treace Medical Concepts, Inc. | 113.96 Million USD | -6.504% |
| Vivos Therapeutics, Inc. | 10.31 Million USD | -1076.296% |
| Acutus Medical, Inc. | 54.83 Million USD | -121.342% |
| Talis Biomedical Corporation | 29.22 Million USD | -315.35% |
| Spectral AI, Inc. | 12.4 Million USD | -878.808% |
| Nano-X Imaging Ltd. | 23.13 Million USD | -424.691% |
| CVRx, Inc. | 39.28 Million USD | -209.002% |
| DIH Holding US, Inc. Warrants | 11.95 Million USD | -915.063% |
| PetVivo Holdings, Inc. | 2.42 Million USD | -4896.583% |
| Bioventus Inc. | 589.79 Million USD | 79.42% |
| Venus Concept Inc. | 107.1 Million USD | -13.332% |
| TriSalus Life Sciences, Inc. | 51.66 Million USD | -134.95% |
| LivaNova PLC | 1.15 Billion USD | 89.463% |
| 908 Devices Inc. | 37.49 Million USD | -223.772% |
| Alphatec Holdings, Inc. | 703.48 Million USD | 82.746% |
| Nemaura Medical Inc. | 26.37 Million USD | -360.174% |
| NeuroPace, Inc. | 86.99 Million USD | -39.524% |
| LENSAR, Inc. | 22.4 Million USD | -441.666% |
| Apyx Medical Corporation | 52.31 Million USD | -132.008% |
| Cutera, Inc. | 518.12 Million USD | 76.573% |
| STRATA Skin Sciences, Inc. | 29.32 Million USD | -313.878% |
| BioSig Technologies, Inc. | 4.68 Million USD | -2490.864% |
| Anika Therapeutics, Inc. | 58.36 Million USD | -107.963% |
| ClearPoint Neuro, Inc. | 21.48 Million USD | -464.883% |
| Integra LifeSciences Holdings Corporation | 2.19 Billion USD | 94.468% |
| Axonics, Inc. | 82.35 Million USD | -47.382% |
| Outset Medical, Inc. | 190.91 Million USD | 36.421% |
| IRIDEX Corporation | 24.91 Million USD | -387.204% |
| PROCEPT BioRobotics Corporation | 123.96 Million USD | 2.084% |
| IRadimed Corporation | 20.73 Million USD | -485.37% |
| Tivic Health Systems, Inc. | 1.67 Million USD | -7151.016% |
| INVO Bioscience, Inc. | 19.99 Million USD | -507.063% |
| Telesis Bio, Inc. | 40.87 Million USD | -196.974% |
| Viemed Healthcare, Inc. | 40.79 Million USD | -197.576% |
| Varex Imaging Corporation | 668.6 Million USD | 81.845% |
| Quipt Home Medical Corp. | 136.29 Million USD | 10.94% |
| Inspira Technologies Oxy B.H.N. Ltd. | 3.57 Million USD | -3298.152% |
| Pulmonx Corporation | 60.63 Million USD | -100.181% |
| Dynatronics Corporation | 11.78 Million USD | -930.397% |
| Modular Medical, Inc. | 2.27 Million USD | -5242.518% |
| ReShape Lifesciences Inc. | 4.06 Million USD | -2886.762% |
| Semler Scientific, Inc. | 6.27 Million USD | -1835.917% |
| InMode Ltd. | 75.91 Million USD | -59.894% |
| Bruker Corporation | 2.83 Billion USD | 95.721% |
| Cytosorbents Corporation | 29.98 Million USD | -304.803% |
| DexCom, Inc. | 4.19 Billion USD | 97.107% |
| Align Technology, Inc. | 2.45 Billion USD | 95.052% |
| Viveve Medical, Inc. | 10.84 Million USD | -1019.038% |
| ZimVie Inc. | 795.85 Million USD | 84.748% |
| Movano Inc. | 5.97 Million USD | -1932.518% |
| Cytek Biosciences, Inc. | 104.6 Million USD | -16.038% |
| Nexalin Technology, Inc. | 425.28 Thousand USD | -28441.6% |
| DIH Holdings US, Inc. Class A Common Stock | 11.95 Million USD | -915.063% |
| Tandem Diabetes Care, Inc. | 639.02 Million USD | 81.005% |
| Profound Medical Corp. | 12.66 Million USD | -858.34% |
| Insulet Corporation | 1.85 Billion USD | 93.458% |
| enVVeno Medical Corporation | 2.43 Million USD | -4884.887% |
| Surmodics, Inc. | 65.82 Million USD | -84.407% |
| iCAD, Inc. | 8 Million USD | -1417.086% |
| Nuwellis, Inc. | 6.78 Million USD | -1690.295% |
| Biotricity, Inc. | 35.91 Million USD | -237.928% |
| iRhythm Technologies, Inc. | 223.04 Million USD | 45.58% |
| Aethlon Medical, Inc. | 2.47 Million USD | -4795.126% |
| InspireMD, Inc. | 8.14 Million USD | -1390.813% |
| PAVmed Inc. | 57.13 Million USD | -112.44% |
| BIOLASE, Inc. | 35.34 Million USD | -243.391% |
| Beyond Air, Inc. | 29.77 Million USD | -307.664% |
| FONAR Corporation | 57.45 Million USD | -111.255% |
| AxoGen, Inc. | 101.16 Million USD | -19.988% |
| Vivani Medical, Inc. | 25.03 Million USD | -384.83% |
| Tactile Systems Technology, Inc. | 87.79 Million USD | -38.255% |
| Inari Medical, Inc. | 209.32 Million USD | 42.013% |
| UFP Technologies, Inc. | 118.04 Million USD | -2.827% |
| QT Imaging Holdings, Inc. | 12.69 Million USD | -856.48% |
| Heart Test Laboratories, Inc. | 2.18 Million USD | -5453.177% |
| Tenon Medical, Inc. | 5.56 Million USD | -2080.384% |
| Autonomix Medical, Inc. Common Stock | 1.77 Million USD | -6723.047% |
| Co-Diagnostics, Inc. | 17.63 Million USD | -588.336% |
| AdaptHealth Corp. | 3.15 Billion USD | 96.15% |
| Sintx Technologies, Inc. | 6.59 Million USD | -1741.074% |
| NanoVibronix, Inc. | 2.68 Million USD | -4419.062% |
| Quanterix Corporation | 78.08 Million USD | -55.451% |
| Inspira Technologies Oxy B.H.N. Ltd. | 3.57 Million USD | -3298.152% |
| Sensus Healthcare, Inc. | 4.88 Million USD | -2384.79% |
| Pacific Biosciences of California, Inc. | 1.04 Billion USD | 88.381% |
| TransMedics Group, Inc. | 568.84 Million USD | 78.662% |
| ReWalk Robotics Ltd. | 16.68 Million USD | -627.623% |
| NeuroMetrix, Inc. | 1.33 Million USD | -9005.079% |
| Hyperfine, Inc. | 9.8 Million USD | -1138.592% |
| Establishment Labs Holdings Inc. | 250.24 Million USD | 51.495% |
| Biomerica, Inc. | 2.66 Million USD | -4458.092% |
| Bone Biologics Corporation | 831.4 Thousand USD | -14499.676% |
| AVITA Medical, Inc. | 19.86 Million USD | -511.022% |
| Bluejay Diagnostics, Inc. | 1.97 Million USD | -6050.025% |
| Silk Road Medical, Inc | 114.15 Million USD | -6.328% |